Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Paula Nay"'
Autor:
Rita Bentahila, Philippe Giraud, Pierre Decazes, Sarah Kreps, Paula Nay, Augustin Chatain, Emmanuelle Fabiano, Catherine Durdux
Publikováno v:
Cancer Medicine, Vol 12, Iss 4, Pp 4170-4183 (2023)
Abstract Background Sarcopenia appears to be a negative prognostic factor for poor survival outcomes and worse treatment tolerance in patients with head‐and‐neck squamous cell carcinoma (HNSCC). We evaluated sarcopenia's impact on overall surviva
Externí odkaz:
https://doaj.org/article/e08758d878fc4e3baa1a4e6001952e25
Autor:
Henri Plais, Marie Labruyère, Thibault Creutin, Paula Nay, Gaëtan Plantefeve, Romain Tapponnier, Maud Jonas, Nadege Tchikangoua Ngapmen, Loïc Le Guennec, Charles De Roquetaillade, Laurent Argaud, Matthieu Jamme, Cyril Goulenok, Karim Merouani, Maxime Leclerc, Bertrand Sauneuf, Sami Shidasp, Annabelle Stoclin, Aurélie Bardet, Olivier Mir, Nusaibah Ibrahimi, Jean-François Llitjos
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundSeveral studies report an increased susceptibility to SARS-CoV-2 infection in cancer patients. However, data in the intensive care unit (ICU) are scarce.Research QuestionWe aimed to investigate the association between active cancer and mort
Externí odkaz:
https://doaj.org/article/443ae125f7fb486aa3582cdc7509bab5
Publikováno v:
Bulletin du Cancer. 110:395-401
Autor:
Rita Bentahila, Philippe Giraud, Pierre Decazes, Sarah Kreps, Paula Nay, Augustin Chatain, Emmanuelle Fabiano, Catherine Durdux
Publikováno v:
Cancer Medicine. 12:4170-4183
Sarcopenia appears to be a negative prognostic factor for poor survival outcomes and worse treatment tolerance in patients with head-and-neck squamous cell carcinoma (HNSCC). We evaluated sarcopenia's impact on overall survival (OS), disease-free sur
Autor:
Alice Bernard-Tessier, Guillaume Mulier, Paula Nay, Capucine Baldini, Laurence Albiges, Emeline Colomba, Ronan Flippot, Pernelle Lavaud, Natacha Naoun, Anna Patrikidou, Yohann Loriot, Christophe Massard, Stéphanie Foulon, Karim Fizazi
Publikováno v:
Journal of Clinical Oncology. 41:221-221
221 Background: AR ligand binding domain (LBD) activating somatic point mutation is a known mechanism of resistance to androgen-receptor signaling inhibitor (ARSI) treatment in mCRPC, leading to a persistent addiction to steroid hormones. Two early p
Publikováno v:
Navus: Revista de Gestão e Tecnologia, Vol 9, Iss 1, Pp 21-36 (2019)
A análise de investimentos busca a avaliação e a seleção de oportunidades que darão à empresa um retorno econômico coerente com suas metas. As empresas, de forma a se manterem competitivas no mercado, precisam selecionar projetos relevantes q
Externí odkaz:
https://doaj.org/article/92544c582b6c45eb995d538d319dd74e